TOMI Environmental Solutions to Present at the H.C. Wainwright Annual Global Investment Conference
TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination and infection prevention company, announced its participation in the H.C. Wainwright 25th Annual Global Investment Conference. The presentation is scheduled for September 10, 2025, at 1:00 PM ET in the Stanford Room at the Lotte New York Palace Hotel in New York City.
CEO Dr. Halden Shane and CFO David Vanston will represent the company, which specializes in disinfection and decontamination through its proprietary Binary Ionization Technology (BIT) platform and SteraMist products. The technology, developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP) for superior disinfection across various sectors including healthcare, biosafety, pharmaceutical, commercial, and education facilities.
TOMI Environmental Solutions (NASDAQ:TOMZ), azienda globale specializzata in decontaminazione e prevenzione delle infezioni, ha annunciato la sua partecipazione al H.C. Wainwright 25th Annual Global Investment Conference. La presentazione si terrà il 10 settembre 2025 alle 13:00 ET nella Stanford Room del Lotte New York Palace Hotel a New York City.
Il CEO Dr. Halden Shane e il CFO David Vanston rappresenteranno la società, che si occupa di disinfezione e decontaminazione con la sua piattaforma proprietaria Binary Ionization Technology (BIT) e i prodotti SteraMist. La tecnologia, sviluppata con un finanziamento DARPA, impiega perossido di idrogeno ionizzato (iHP) per garantire una disinfezione avanzata in ambito sanitario, biosicurezza, farmaceutico, commerciale e scolastico.
TOMI Environmental Solutions (NASDAQ:TOMZ), compañía global dedicada a la descontaminación y prevención de infecciones, anunció su participación en la H.C. Wainwright 25th Annual Global Investment Conference. La presentación está programada para el 10 de septiembre de 2025 a la 1:00 PM ET en la Stanford Room del Lotte New York Palace Hotel en la ciudad de Nueva York.
El CEO Dr. Halden Shane y el CFO David Vanston representarán a la empresa, que se especializa en desinfección y descontaminación mediante su plataforma propietaria Binary Ionization Technology (BIT) y los productos SteraMist. La tecnología, desarrollada con una subvención de defensa de DARPA, utiliza peróxido de hidrógeno ionizado (iHP) para ofrecer una desinfección superior en sectores como la salud, bioseguridad, farmacéutica, comercial y educativa.
TOMI Environmental Solutions (NASDAQ:TOMZ), 전 세계 오염 제거 및 감염 예방 기업이 H.C. Wainwright 25th Annual Global Investment Conference에 참가한다고 발표했습니다. 발표는 2025년 9월 10일 동부시간 오후 1시, 뉴욕시 롯데 뉴욕 팰리스 호텔의 스탠포드 룸에서 열립니다.
CEO인 Dr. Halden Shane과 CFO David Vanston이 회사를 대표할 예정이며, 회사는 독자적인 Binary Ionization Technology (BIT) 플랫폼과 SteraMist 제품을 통해 소독 및 오염 제거를 전문으로 하고 있습니다. DARPA 방위 보조금으로 개발된 이 기술은 이온화된 과산화수소(iHP)를 사용해 의료, 생물안전, 제약, 상업 및 교육 시설 등 다양한 분야에서 우수한 소독 효과를 제공합니다.
TOMI Environmental Solutions (NASDAQ:TOMZ), entreprise mondiale de décontamination et de prévention des infections, a annoncé sa participation à la H.C. Wainwright 25th Annual Global Investment Conference. La présentation est prévue le 10 septembre 2025 à 13h00 ET dans la Stanford Room du Lotte New York Palace Hotel à New York.
Le PDG Dr. Halden Shane et le CFO David Vanston représenteront la société, spécialisée dans la désinfection et la décontamination grâce à sa plateforme propriétaire Binary Ionization Technology (BIT) et aux produits SteraMist. La technologie, développée grâce à une subvention de défense DARPA, utilise du peroxyde d'hydrogène ionisé (iHP) pour offrir une désinfection performante dans les secteurs de la santé, de la biosécurité, pharmaceutique, commercial et éducatif.
TOMI Environmental Solutions (NASDAQ:TOMZ), ein weltweit tätiges Unternehmen für Dekontamination und Infektionsprävention, hat seine Teilnahme an der H.C. Wainwright 25th Annual Global Investment Conference angekündigt. Die Präsentation findet am 10. September 2025 um 13:00 Uhr ET im Stanford Room des Lotte New York Palace Hotel in New York City statt.
CEO Dr. Halden Shane und CFO David Vanston werden das Unternehmen vertreten, das sich auf Desinfektion und Dekontamination mit seiner proprietären Binary Ionization Technology (BIT) Plattform und den SteraMist-Produkten spezialisiert hat. Die unter einer DARPA-Förderung entwickelte Technologie nutzt ionisiertes Wasserstoffperoxid (iHP) für überlegene Desinfektionsleistungen in Bereichen wie Gesundheitswesen, Biosicherheit, Pharma, Gewerbe und Bildungseinrichtungen.
- None.
- None.
FREDERICK, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced that Dr. Halden Shane, Chief Executive Officer, and David Vanston, Chief Financial Officer, will be participating in the H.C. Wainwright 25th Annual Global Investment Conference to be held September 8-10, 2025 at the Lotte New York Palace Hotel in New York City.
Presentation details are as follows:
Date: Wednesday, September 10, 2025
Time: 1:00pm ET
Room: Stanford Room, 4th Floor
The Company will also be available for one-on-one meetings throughout the conference.
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology ® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit http://www.steramist.com/ or contact us at info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to conference participation. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
